AMITIZA (lubiprostone) Sucampo pharma llc Patent: 7,795,312 Expiration: Sep 17, 2024 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of September 15, 2024 Read Post »
Introduction Biosimilars, which are highly similar versions of biologic drugs, have the potential to significantly reduce healthcare costs by offering
Enhancing Your Product Portfolio with CDMOs: A Strategic Partnership for Pharmaceutical Success The pharmaceutical industry is constantly evolving, driven by […]
In the high-stakes world of pharmaceuticals, where innovation meets profit, a little-known regulatory program called REMS (Risk Evaluation and Mitigation […]
REMS: The Regulatory Shield Blocking Affordable Generics Read Post »
Introduction Navigating the biotech funding ecosystem can be a daunting task for startups. The biotech industry is characterized by high
Introduction Biotech companies face unique financial challenges due to the lengthy and costly process of developing and commercializing biotech products.
The Role of Strategic Planning in Biotech Financing Read Post »
In the labyrinthine world of pharmaceuticals, where the cost of life-saving medications can often feel like a roll of the […]
The ‘Rule of Three’: How the FDA is Hacking Drug Prices Read Post »
The pharmaceutical industry has long been a cornerstone of healthcare, providing essential medications to treat a wide range of diseases.
How Biotechnology is Revolutionizing the Pharmaceutical Industry Read Post »
The pharmaceutical industry has witnessed significant advancements in recent years, particularly in the realm of nanotechnology. This innovative field has […]
Leveraging Nanotechnology in Generic Drug Development: Enhancing Efficacy and Safety Read Post »
The generic drug market has experienced significant growth over the past few decades, driven by the passage of the Hatch-Waxman […]
Optimizing Partnerships for Generic Drug Development Success Read Post »
Get new actionable insights and updates from BiotechBlog
